SPEAKER INDEX CONTENTS INSERTS
ABRAMSON 105 117 122 123 124 125 126 133 136
137 138
AMY CARROLL 5
BAIRD 25 118 119 120 121 122 123 124 135
136 137 138 139 140
EHLERS 19 24 27 28 33 38 60 69 77
80 81 105 113
ERIC WEBSTER 4
ESKESEN 34 38 119 127 140 141
GRAVES 28 29 33
JAMIE BROWN 5
JEAN FRUCI 4
JONATHAN COHEN 69 115 116 118 124 129 135 138
MARTY SPITZER 5
MIKE QUEAR 4
MILLER 125 126 127 128 130 132 134
NACY 78 80 81 117 121 122 124 127 131
132 135 137 140
OLWEN HUXLEY 5
RON COHEN 60 114 120 126 130 133 139
SCHWARZ 113 116 118 125 128 130 132 134 135
136 140 141
SUSANNAH FOSTER 5
CONTENTS SPEAKERS INSERTS
STATEMENT OF HON. SAM GRAVES, A REPRESENTATIVE IN CONGRESS FROM THE STATE OF MISSOURI
PAGE 28
STATEMENT OF MS. ANN ESKESEN, PRESIDENT, INNOVATION DEVELOPMENT INSTITUTE, SWAMPSCOTT,
MASSACHUSETTS
PAGE 34
STATEMENT OF DR. RON COHEN, PRESIDENT AND CEO, ACORDA THERAPEUTICS, INC.
PAGE 60
STATEMENT OF MR. JONATHAN COHEN, PRESIDENT AND CEO, 20/20 GENE SYSTEMS, INC.
PAGE 69
STATEMENT OF DR. CAROL A. NACY, CHIEF EXECUTIVE OFFICER, SEQUELLA, INC.
PAGE 78
STATEMENT OF DR. FREDERIC D. ABRAMSON, PRESIDENT AND CEO, ALPHAGENICS, INC.
PAGE 105
INSERTS SPEAKERS CONTENTS
NO INSERTS IN THIS HEARING